Cytovale, Inc.

Cytovale, Inc. — FDA 510(k) Submissions

Cytovale, Inc. has submitted 3 FDA 510(k) premarket notifications since 2022, of which 3 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Deformability Cytometry For Sepsis Risk Assessment . Use the specialty filter in the sidebar to narrow results.